The supplementary domain in SDTM: good, bad and ugly
All you need to know about the supplementary domain in SDTM The supplementary domain in…
CertaraJuly 2, 2020
Data Validation in Clinical Research: Confusing Rules Explained
In this webinar, we explore what you should do when rules fire during data validation…
CertaraApril 30, 2020
The Rare Disease Drug Dilemma: Great Value, High Price, Limited Access?
This webinar will explain how pricing has evolved for the rare disease drug market and…
CertaraFebruary 19, 2020
How to Demonstrate Virtual Bioequivalence for Complex Dermal Generic Drugs
This webinar will explain how Certara expanded its PBPK Simcyp Simulator to incorporate an extensive…
CertaraJanuary 24, 2020
How to Perform IVIVC for Delayed Release Drug Formulations
This webinar showed how to use a time correction factor to establish a meaningful IVIVC…
CertaraAugust 20, 2019
Innovative Solutions for Fast-Tracking Drugs for Rare Diseases
This webinar discussed which pharmaceutical payer strategies work and which don't in our rapidly changing…
CertaraAugust 10, 2019
Advanced Analytics Using RWD Mitigates Risks in AD Drug Development & Reimbursement
This webinar explained how advanced analytics using real-world data can mitigate challenges in Alzheimer’s disease…
CertaraMay 13, 2019
How to Perform IVIVC for Extremely Long Acting Drugs
Watch this webinar to learn how to use in vitro and in vivo models to…
CertaraFebruary 22, 2019
